UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Decreased utilization of mental health emergency service during the COVID-19 pandemic

European archives of psychiatry and clinical neuroscience, 2021-03, Vol.271 (2), p.377-379

2021

Volltextzugriff (PDF)

Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study

European archives of psychiatry and clinical neuroscience, 2014-04, Vol.264 (3), p.255-261

2014

Volltextzugriff (PDF)

Methylome-wide change associated with response to electroconvulsive therapy in depressed patients

Translational psychiatry, 2021-06, Vol.11 (1), p.347-347, Article 347

2021

Volltextzugriff (PDF)

Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality

European archives of psychiatry and clinical neuroscience, 2021-04, Vol.271 (3), p.457-463

2021

Volltextzugriff (PDF)

Electroconvulsive therapy increases temporal gray matter volume and cortical thickness

European neuropsychopharmacology, 2016-03, Vol.26 (3), p.506-517

2016

Volltextzugriff (PDF)

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia

Schizophrenia research, 2013-11, Vol.150 (2), p.519-525

2013

Volltextzugriff (PDF)

The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid

European archives of psychiatry and clinical neuroscience, 2020-10, Vol.270 (7), p.911-919

2020

Volltextzugriff (PDF)

Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression

Translational psychiatry, 2023-09, Vol.13 (1), p.294-294, Article 294

2023

Volltextzugriff (PDF)

Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing

The Journal of neuroscience, 2014-04, Vol.34 (17), p.5909-5917

2014

Volltextzugriff (PDF)

Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia

Biomarker insights, 2010, Vol.2010 (5), p.BMI.S4877

2010

Volltextzugriff (PDF)

CSF metabolic and proteomic profiles in patients prodromal for psychosis

PloS one, 2007-08, Vol.2 (8), p.e756-e756

2007

Volltextzugriff (PDF)

A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: Validation

European archives of psychiatry and clinical neuroscience, 2019-10, Vol.269 (7), p.859-865

2019

Volltextzugriff (PDF)

Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels

Neuroscience letters, 2019-06, Vol.704, p.164-168

2019

Volltextzugriff (PDF)

Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study

Journal of affective disorders, 2019-06, Vol.253, p.449-453

2019

Volltextzugriff (PDF)

Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study

European archives of psychiatry and clinical neuroscience, 2011-12, Vol.261 (8), p.575-582

2011

Volltextzugriff (PDF)

Identification of a biological signature for schizophrenia in serum

Molecular psychiatry, 2012-05, Vol.17 (5), p.494-502

2012

Volltextzugriff (PDF)

Cytokine-mediated cellular immune activation in electroconvulsive therapy: A CSF study in patients with treatment-resistant depression

The world journal of biological psychiatry, 2020-02, Vol.21 (2), p.139-147

2020

Volltextzugriff (PDF)

Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute stroke

Neuropsychiatric disease and treatment, 2019-07, Vol.15, p.1823-1831

2019

Volltextzugriff (PDF)

Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression

Journal of Neural Transmission, 2017-12, Vol.124 (12), p.1641-1645

2017

Volltextzugriff (PDF)

A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development

European archives of psychiatry and clinical neuroscience, 2018-12, Vol.268 (8), p.819-830

2018

Volltextzugriff (PDF)

Electroconvulsive Stimulation in Rats Induces Alterations in the Hippocampal miRNome: Translational Implications for Depression

Molecular neurobiology, 2023-03, Vol.60 (3), p.1150-1163

2023

Volltextzugriff (PDF)

Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients

European archives of psychiatry and clinical neuroscience, 2015-04, Vol.265 (3), p.227-232

2015

Volltextzugriff (PDF)

Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study

European archives of psychiatry and clinical neuroscience, 2017-12, Vol.267 (8), p.781-786

2017

Volltextzugriff (PDF)

Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression

Journal of Neural Transmission, 2014-11, Vol.121 (11), p.1411-1415

2014

Volltextzugriff (PDF)

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients

Molecular psychiatry, 2011-08, Vol.16 (8), p.848-859

2011

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(66)
Berichte
(2)

Sprache

Englisch
(68)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(53)
Psychiatry
(48)
Humans
(45)
Female
(40)
Male
(37)
Neurosciences & Neurology
(32)
Electroconvulsive Therapy
(31)
Neurosciences
(30)
Adult
(28)
Depression
(26)
Middle Aged
(25)
Clinical Neurology
(24)
Aged
(21)
Ect
(19)
Electroconvulsive Therapy - Methods
(18)
Depressive Disorder, Major - Therapy
(17)
Medicine
(17)
Medicine & Public Health
(16)
Young Adult
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Decreased utilization of mental health emergency service during the COVID-19 pandemic

Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study

Methylome-wide change associated with response to electroconvulsive therapy in depressed patients

Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality

Electroconvulsive therapy increases temporal gray matter volume and cortical thickness

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia

The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid

Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression

Source-reconstruction of event-related fields reveals hyperfunction and hypofunction of cortical circuits in antipsychotic-naive, first-episode schizophrenia patients during Mooney face processing

Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia

CSF metabolic and proteomic profiles in patients prodromal for psychosis

A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: Validation

Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels

Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study

Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study

Identification of a biological signature for schizophrenia in serum

Cytokine-mediated cellular immune activation in electroconvulsive therapy: A CSF study in patients with treatment-resistant depression

Impact of psychiatric comorbidity on the severity, short-term functional outcome, and psychiatric complications after acute stroke

Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression

A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development

Electroconvulsive Stimulation in Rats Induces Alterations in the Hippocampal miRNome: Translational Implications for Depression

Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients

Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study

Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression

Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients

Suchergebnisse filtern